The antitumor immune response in HER-2 positive, metastatic breast cancer patients

The aim of this study was to determine the basis for anti-tumor immune reactivity observed in patients with human epidermal growth factor receptor-2 (HER-2) (3+) breast carcinoma using an in vitro model in which the role of the HER-2-specific monoclonal antibody Herceptin was also investigated. Pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Juranic, Zorica D, Neskovic-Konstantinovic, Zora, Stanojkovic, Tatjana P, Zizak, Zeljko, Srdic, Tatjana, Stanojevic-Bakic, Nevenka, Milosevic, Dusanka, Jovanovic, Danica
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079956/
https://www.ncbi.nlm.nih.gov/pubmed/15784149
http://dx.doi.org/10.1186/1479-5876-3-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079956/
https://www.ncbi.nlm.nih.gov/pubmed/15784149
http://dx.doi.org/10.1186/1479-5876-3-13

Ejemplares similares